Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Non-Seminomatous Germ Cell Tumors

PURPOSE: Patients with good risk nonseminomatous germ cell tumors receive induction chemotherapy with either 4 cycles of etoposide and platinum (EPx4) or three cycles of bleomycin, etoposide, and platinum (BEPx3). We report the histologic results at post-chemotherapy retroperitoneal lymph node disse...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Urol
Auteurs principaux: Kundu, Shilajit D., Feldman, Darren R., Carver, Brett S., Gupta, Amit, Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354932/
https://ncbi.nlm.nih.gov/pubmed/25150639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.08.081
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires